jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Aug. 06, 2024

Aug. 06, 2024

jRCT1030240253

Stratum corneum sampling study for validation of analytical method for drug concentration in human stratum corneum

Stratum corneum sampling study for validation of analytical method for drug concentration in human stratum corneum

Takazawa Kenji

Medical Corporation Shinanokai Shinanozaka Clinic

3F Yotsuya Medical Building, 20 Samoncho, Shinjuku-ku, Tokyo

+81-3-5366-3006

m-kinomoto@trcp.co.jp

Kinomoto Mikito

Tokyo Research Center of Clinical Pharmacology Co., Ltd.

Yotsuya Medical Building, 20 Samoncho, Shinjuku-ku, Tokyo

+81-3-5366-3006

m-kinomoto@trcp.co.jp

Pending

July. 29, 2024

6

Observational

single arm study

open(masking not used)

uncontrolled control

single assignment

other

(1) Age: 20 to 40 years old (at the time of obtaining consent)
(2) Persons whose BMI [Body Mass Index: weight (kg) / height (mm)2] is 18.5 kg/m2 or more and less than 25 kg/m2 (numbers are not rounded).

Persons with have skin wounds at the site of stratum corneum collection, and those who have skin symptoms such as eczema, contact dermatitis, psoriasis, seborrheic dermatitis, dyschromatosis, and excessive sunburn at the site of stratum corneum collection.

20age old over
40age old under

Male

Pain relief and anti-inflammation

Stratum corneum sampling
TEWL measurement value

none

Lead Chemical Co., Ltd.
Medical Corporation Shinanokai Shinanozaka Clinic Ethics Committee
Yotsuya Medical Building, 20 Samoncho, Shinjuku-ku, Tokyo, Tokyo

+81-3-5366-3006

scl-irb@shinanokai.com
Approval

July. 23, 2024

No

none